Free Trial

Citigroup Reiterates "Buy" Rating for Centrica (LON:CNA)

Centrica logo with Utilities background

Key Points

  • Citigroup has reaffirmed a "buy" rating for Centrica (LON:CNA) based on its recent analysis, indicating confidence in the stock's future performance.
  • Centrica's latest earnings report showed an earnings per share of GBX 7 ($0.09) with a net margin of 5.39% and a return on equity of 25.16%.
  • Insider transactions include the sale of over 770,000 shares by Chris O'Shea, valued at around £1.3 million, alongside a smaller purchase by Philippe Boisseau.
  • Five stocks to consider instead of Centrica.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Centrica (LON:CNA - Get Free Report)'s stock had its "buy" rating reaffirmed by investment analysts at Citigroup in a research note issued to investors on Friday,Digital Look reports.

Centrica Trading Down 0.2%

LON CNA opened at GBX 160.21 ($2.16) on Friday. The company has a quick ratio of 0.40, a current ratio of 1.77 and a debt-to-equity ratio of 66.48. Centrica has a 52 week low of GBX 112.99 ($1.53) and a 52 week high of GBX 168.90 ($2.28). The stock has a market capitalization of £8.01 billion, a PE ratio of 7.64, a price-to-earnings-growth ratio of 0.45 and a beta of 1.08. The firm has a 50 day moving average of GBX 159.90 and a two-hundred day moving average of GBX 149.88.

Centrica (LON:CNA - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The integrated energy company reported GBX 7 ($0.09) earnings per share for the quarter. Centrica had a net margin of 5.39% and a return on equity of 25.16%.

Insider Buying and Selling at Centrica

In related news, insider Chris O’Shea sold 770,946 shares of the company's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of GBX 168 ($2.27), for a total value of £1,295,189.28 ($1,749,546.51). Also, insider Philippe Boisseau purchased 1,016 shares of Centrica stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average price of GBX 166 ($2.24) per share, with a total value of £1,686.56 ($2,278.21). In the last quarter, insiders purchased 4,494 shares of company stock valued at $718,408. 0.20% of the stock is owned by insiders.

Centrica Company Profile

(Get Free Report)

Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK's largest energy services workforce.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centrica Right Now?

Before you consider Centrica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centrica wasn't on the list.

While Centrica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines